Intravenous Albumin and Diuretic in Nephrotic Syndrome with Severe Edema: Our Experience and Literature Review Albumin infusion
Journal of Pediatric Nephrology,
Vol. 9 No. 1 (2021),
3 January 2021
,
Page 1-4
https://doi.org/10.22037/jpn.v9i1.32401
Abstract
Background and Aim: Steroids are the mainstay of initial treatment in children with Idiopathic Nephrotic Syndrome (INS). The role of diuretics in children with NS is less clear in comparison to adults. In cases with severe or refractory edema, furosemide is often combined with albumin infusion (0.5 to 1 g/kg) to provide symptomatic relief.
Methods: This study was a retrospective chart review of 17 patients with a diagnosis of Steroid Dependent Nephrotic Syndrome (SDNS) admitted for relapse of NS with severe edema who were resistant to diuretic therapy alone. The patients were treated as per unit protocol with an infusion of 100 ml intravenous albumin 20% over 4 hours and 2 doses (one in the morning at 10 AM and the other in the evening at 6 PM) of furosemide 1mg/kg for 3 days. Response to therapy and adverse events were evaluated.
Results: The mean age of the study population was 10.58±1.5 years. All of the patients had severe edema and none of them had responded to intravenous diuretics alone. After co-administration of intravenous albumin infusion and furosemide, the mean weight loss per day per patient was 0.87±0.16 kg.
Conclusion: A significant improvement was noted in all of the patients following co-administration of albumin and furosemide without any adverse events.
- Nephrotic Syndrome
- Steroid
- Diuretic
- Children
How to Cite
References
2. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. (1981). The Journal of pediatrics, 98(4), 561–564. https://doi.org/10.1016/s0022-3476(81)80760-3
3. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children. (1984). Pediatrics, 73(4), 497–501.
4. Tarshish, P., Tobin, J. N., Bernstein, J., & Edelmann, C. M., Jr (1997). Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. Journal of the American Society of Nephrology : JASN, 8(5), 769–776.
5. Cadnapaphornchai, M. A., Tkachenko, O., Shchekochikhin, D., & Schrier, R. W. (2014). The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatric nephrology (Berlin, Germany), 29(7), 1159–1167. https://doi.org/10.1007/s00467-013-2567-8
6. Haws, R. M., & Baum, M. (1993). Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics, 91(6), 1142–1146.
7. Reid, C. J., Marsh, M. J., Murdoch, I. M., & Clark, G. (1996). Nephrotic syndrome in childhood complicated by life threatening pulmonary oedema. BMJ (Clinical research ed.), 312(7022), 36–38. https://doi.org/10.1136/bmj.312.7022.36
8. McCaffrey, J., Lennon, R., & Webb, N. J. (2016). The non-immunosuppressive management of childhood nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 31(9), 1383–1402. https://doi.org/10.1007/s00467-015-3241-0
9. Gipson, D. S., Massengill, S. F., Yao, L., Nagaraj, S., Smoyer, W. E., Mahan, J. D., Wigfall, D., Miles, P., Powell, L., Lin, J. J., Trachtman, H., & Greenbaum, L. A. (2009). Management of childhood onset nephrotic syndrome. Pediatrics, 124(2), 747–757. https://doi.org/10.1542/peds.2008-1559
10. Willemsen, R. H., Delgado-Carballar, V., Elleri, D., Thankamony, A., Burke, G. A., Nicholson, J. C., & Dunger, D. B. (2016). Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH. Endocrinology, diabetes & metabolism case reports, 2016, 16-0066. https://doi.org/10.1530/EDM-16-0066
11. Vande Walle, J., Donckerwolcke, R., Boer, P., van Isselt, H. W., Koomans, H. A., & Joles, J. A. (1996). Blood volume, colloid osmotic pressure and F-cell ratio in children with the nephrotic syndrome. Kidney international, 49(5), 1471–1477. https://doi.org/10.1038/ki.1996.207
12. Geers, A. B., Koomans, H. A., Boer, P., & Dorhout Mees, E. J. (1984). Plasma and blood volumes in patients with the nephrotic syndrome. Nephron, 38(3), 170–173. https://doi.org/10.1159/000183302
13. EPSTEIN A. A. (1952). Concerning the causation of edema in chronic parenchymatous nephritis; method for its alleviation. The American journal of medicine, 13(5), 556–561. https://doi.org/10.1016/0002-9343(52)90020-x
14. Humphreys M. H. (1994). Mechanisms and management of nephrotic edema. Kidney international, 45(1), 266–281. https://doi.org/10.1038/ki.1994.33
15. Meltzer, J. I., Keim, H. J., Laragh, J. H., Sealey, J. E., Jan, K. M., & Chien, S. (1979). Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Annals of internal medicine, 91(5), 688–696. https://doi.org/10.7326/0003-4819-91-5-688
16. Palmer, B. F., & Alpern, R. J. (1997). Pathogenesis of edema formation in the nephrotic syndrome. Kidney international. Supplement, 59, S21–S27.
17. Dorhout Mees, E. J., & Koomans, H. A. (1995). Understanding the nephrotic syndrome: what's new in a decade?. Nephron, 70(1), 1–10. https://doi.org/10.1159/000188535
18. Schrier, R. W., & Fassett, R. G. (1998). A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney international, 53(5), 1111–1117. https://doi.org/10.1046/j.1523-1755.1998.00864.x
19. Vande Walle, J. G., Donckerwolcke, R. A., van Isselt, J. W., Derkx, F. H., Joles, J. A., & Koomans, H. A. (1995). Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet (London, England), 346(8968), 148–152. https://doi.org/10.1016/s0140-6736(95)91210-x
20. Kapur, G., Valentini, R. P., Imam, A. A., & Mattoo, T. K. (2009). Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study. Clinical journal of the American Society of Nephrology : CJASN, 4(5), 907–913. https://doi.org/10.2215/CJN.04390808
21. Inoue, M., Okajima, K., Itoh, K., Ando, Y., Watanabe, N., Yasaka, T., Nagase, S., & Morino, Y. (1987). Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney international, 32(2), 198–203. https://doi.org/10.1038/ki.1987.192
22. Weiss, R. A., Schoeneman, M., & Greifer, I. (1984). Treatment of severe nephrotic edema with albumin and furosemide. New York state journal of medicine, 84(8), 384–386.
23. Bircan, Z., Kervancioğlu, M., Katar, S., & Vitrinel, A. (2001). Does albumin and furosemide therapy affect plasma volume in nephrotic children?. Pediatric nephrology (Berlin, Germany), 16(6), 497–499. https://doi.org/10.1007/s004670100576
24. Dharmaraj, R., Hari, P., & Bagga, A. (2009). Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatric nephrology (Berlin, Germany), 24(4), 775–782. https://doi.org/10.1007/s00467-008-1062-0
25. Na, K. Y., Han, J. S., Kim, Y. S., Ahn, C., Kim, S., Lee, J. S., Bae, K. S., Jang, I. J., Shin, S. G., Huh, W., & Jeon, U. S. (2001). Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?. Journal of Korean medical science, 16(4), 448–454. https://doi.org/10.3346/jkms.2001.16.4.448
26. Sjöström, P. A., Odlind, B. G., Beermann, B. A., & Karlberg, B. E. (1989). Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome. European journal of clinical pharmacology, 37(2), 173–180. https://doi.org/10.1007/BF00558227
27. Fliser, D., Zurbrüggen, I., Mutschler, E., Bischoff, I., Nussberger, J., Franek, E., & Ritz, E. (1999). Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney international, 55(2), 629–634. https://doi.org/10.1046/j.1523-1755.1999.00298.x
28. Ghafari, A., Mehdizadeh, A., Alavi-Darazam, I., Rahimi, E., Kargar, C., & Sepehrvand, N. (2011). Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 22(3), 471–475.
29. Ho, J. J., Adnan, A. S., Kueh, Y. C., Ambak, N. J., Van Rostenberghe, H., & Jummaat, F. (2019). Human albumin infusion for treating oedema in people with nephrotic syndrome. The Cochrane database of systematic reviews, 7(7), CD009692. Advance online publication. https://doi.org/10.1002/14651858.CD009692.pub2
30. Chalasani, N., Gorski, J. C., Horlander , J. C., Sr, Craven, R., Hoen, H., Maya, J., & Brater, D. C. (2001). Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. Journal of the American Society of Nephrology : JASN, 12(5), 1010–1016.
31. Kitsios, G. D., Mascari, P., Ettunsi, R., & Gray, A. W. (2014). Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. Journal of critical care, 29(2), 253–259. https://doi.org/10.1016/j.jcrc.2013.10.004
32. Liumbruno, G. M., Bennardello, F., Lattanzio, A., Piccoli, P., Rossettias, G., & Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) (2009). Recommendations for the use of albumin and immunoglobulins. Blood transfusion = Trasfusione del sangue, 7(3), 216–234. https://doi.org/10.2450/2009.0094-09
- Abstract Viewed: 831 times
- PDF Downloaded: 409 times